United States Biotechnology & Medical Research

Audentes Therapeutics Inc (BOLD)

Track

Ticker: BOLD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 23 Dec 2019
Value US$463,419.29 | Price 96.49 | Shares 28,001 (-41.5%)
Planned sale 23 Dec 2019
Value US$102,320.22 | Price 413.00 | Shares 26,601 (+45.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-27 2019-12-23 PlS Planned sale LANGE LOUIS G Non-Executive Director
28,001 -41.5%
96.49
US$463,419 		28,001 -41.5% 96.49 US$463,419
2019-12-27 2019-12-23 PlS Planned sale LANGE LOUIS G Non-Executive Director
26,601 +45.7%
413.00
US$102,320 		26,601 +45.7% 413.00 US$102,320
2019-11-12 2019-11-08 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
67,591 +31.4%
139.34
US$3,264,867 		67,591 +31.4% 139.34 US$3,264,867
2019-09-25 2019-09-23 PlS Planned sale
2.2
LANGE LOUIS G
1,000 -6.4%
32.18
US$32,182 		1,000 -6.4% 32.18 US$32,182
2019-09-25 2019-09-23 PlS Planned sale
2.2
LANGE LOUIS G
245 -0.1%
32.66
US$8,002 		245 -0.1% 32.66 US$8,002
2019-09-25 2019-09-23 PlS Planned sale
2.2
LANGE LOUIS G
9,755 -3.4%
32.15
US$313,613 		9,755 -3.4% 32.15 US$313,613
2019-08-14 2019-08-12 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
1,000 -0.9%
34.53
US$34,525 		1,000 -0.9% 34.53 US$34,525
2019-08-14 2019-08-12 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
19,000 -14.0%
34.02
US$646,310 		19,000 -14.0% 34.02 US$646,310
2019-06-26 2019-06-24 PlS Planned sale
2.2
LANGE LOUIS G
200 -1.3%
39.46
US$7,892 		200 -1.3% 39.46 US$7,892
2019-06-26 2019-06-24 PlS Planned sale
2.2
LANGE LOUIS G
800 -4.8%
37.89
US$30,309 		800 -4.8% 37.89 US$30,309
2019-06-26 2019-06-24 PlS Planned sale
2.2
LANGE LOUIS G
600 -0.2%
40.00
US$23,998 		600 -0.2% 40.00 US$23,998
2019-06-26 2019-06-24 PlS Planned sale
2.2
LANGE LOUIS G
3,602 -1.2%
38.15
US$137,409 		3,602 -1.2% 38.15 US$137,409
2019-06-26 2019-06-24 PlS Planned sale
2.2
LANGE LOUIS G
15,798 -5.2%
37.60
US$594,005 		15,798 -5.2% 37.60 US$594,005
2019-05-15 2019-05-13 PlS Planned sale
PRASAD SUYASH

Senior VP & Chief Med Officer
54 -0.3%
37.72
US$2,037 		54 -0.3% 37.72 US$2,037
2019-05-15 2019-05-13 PlS Planned sale
PRASAD SUYASH

Senior VP & Chief Med Officer
9,946 -35.2%
36.98
US$367,761 		9,946 -35.2% 36.98 US$367,761
2019-03-27 2019-03-25 PlS Planned sale
2.2
LANGE LOUIS G
Non-Executive Director
558 -100.0%
35.94
US$20,055 		558 -100.0% 35.94 US$20,055
2019-03-27 2019-03-25 PlS Planned sale
2.2
LANGE LOUIS G
Non-Executive Director
1,000 -5.7%
36.00
US$36,004 		1,000 -5.7% 36.00 US$36,004
2019-03-27 2019-03-25 PlS Planned sale
2.2
LANGE LOUIS G
Non-Executive Director
300 -0.1%
36.64
US$10,992 		300 -0.1% 36.64 US$10,992
2019-03-27 2019-03-25 PlS Planned sale
2.2
LANGE LOUIS G
Non-Executive Director
19,700 -6.0%
35.99
US$709,023 		19,700 -6.0% 35.99 US$709,023
2019-02-27 2019-02-25 PlS Planned sale
PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
10,000 -35.4%
30.06
US$300,553 		10,000 -35.4% 30.06 US$300,553
2019-02-27 2019-02-25 PlS Planned sale
Patterson Matthew R

Chief Executive Officer

Executive Director
4,000 -3.3%
30.00
US$120,000 		4,000 -3.3% 30.00 US$120,000
2019-02-27 2019-02-25 PlS Planned sale
Patterson Matthew R

Chief Executive Officer

Executive Director
17,000 -12.5%
30.00
US$510,000 		17,000 -12.5% 30.00 US$510,000
2018-12-27 2018-12-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
10,000 -23.6%
18.50
US$184,951 		10,000 -23.6% 18.50 US$184,951
2018-12-27 2018-12-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
1,000 -64.2%
18.71
US$18,713 		1,000 -64.2% 18.71 US$18,713
2018-12-27 2018-12-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
1,000 -5.4%
18.70
US$18,701 		1,000 -5.4% 18.70 US$18,701
2018-12-27 2018-12-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
20,000 -5.8%
18.67
US$373,434 		20,000 -5.8% 18.67 US$373,434
2018-11-16 2018-11-15 S Sale LANGE LOUIS G Non-Executive Director
4,000 -52.9%
22.49
US$89,960 		4,000 -52.9% 22.49 US$89,960
2018-11-16 2018-11-15 S Sale LANGE LOUIS G Non-Executive Director
20,000 -5.5%
22.49
US$449,800 		20,000 -5.5% 22.49 US$449,800
2018-10-02 2018-10-01 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
4,699 -100.0%
35.60
US$167,283 		4,699 -100.0% 35.60 US$167,283
2018-10-02 2018-10-01 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
200 -100.0%
36.32
US$7,263 		200 -100.0% 36.32 US$7,263
2018-10-02 2018-10-01 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
3,900 -100.0%
37.82
US$147,512 		3,900 -100.0% 37.82 US$147,512
2018-10-02 2018-10-01 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
1,101 -100.0%
38.85
US$42,777 		1,101 -100.0% 38.85 US$42,777
2018-10-02 2018-10-01 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
100 -100.0%
39.52
US$3,952 		100 -100.0% 39.52 US$3,952
2018-10-02 2018-10-01 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
8,078 -35.0%
37.70
US$304,573 		8,078 -35.0% 37.70 US$304,573
2018-10-02 2018-10-01 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
5,448 -26.6%
38.58
US$210,162 		5,448 -26.6% 38.58 US$210,162
2018-10-02 2018-10-01 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
5,330 -26.2%
38.04
US$202,732 		5,330 -26.2% 38.04 US$202,732
2018-10-02 2018-10-01 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
2,144 -12.5%
39.14
US$83,905 		2,144 -12.5% 39.14 US$83,905
2018-10-02 2018-09-28 PlS Planned sale GRAY JOHN T.

SVP, Chief Scientific Officer

Officer
87 -100.0%
40.00
US$3,480 		87 -100.0% 40.00 US$3,480
2018-09-26 2018-09-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
10,000 -19.1%
37.45
US$374,536 		10,000 -19.1% 37.45 US$374,536
2018-09-26 2018-09-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
1,000 -39.1%
37.27
US$37,267 		1,000 -39.1% 37.27 US$37,267
2018-09-26 2018-09-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
1,000 -5.1%
37.27
US$37,266 		1,000 -5.1% 37.27 US$37,266
2018-09-26 2018-09-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
1,000 -11.7%
37.25
US$37,250 		1,000 -11.7% 37.25 US$37,250
2018-09-26 2018-09-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
200 -0.1%
37.76
US$7,551 		200 -0.1% 37.76 US$7,551
2018-09-26 2018-09-24 PlS Planned sale LANGE LOUIS G Non-Executive Director
19,800 -5.1%
37.35
US$739,510 		19,800 -5.1% 37.35 US$739,510
2018-09-20 2018-09-18 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
12,952 -100.0%
40.00
US$518,080 		12,952 -100.0% 40.00 US$518,080
2018-07-05 2018-07-05 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
23,147 -100.0%
40.04
US$926,852 		23,147 -100.0% 40.04 US$926,852
2018-07-05 2018-07-03 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
26,901 -100.0%
40.05
US$1,077,460 		26,901 -100.0% 40.05 US$1,077,460
2018-07-05 2018-07-02 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
5,011 -100.0%
38.79
US$194,364 		5,011 -100.0% 38.79 US$194,364
2018-07-05 2018-07-02 PlS Planned sale PRASAD SUYASH

Senior VP & Chief Med Officer

Officer
4,989 -100.0%
38.02
US$189,704 		4,989 -100.0% 38.02 US$189,704
2018-07-05 2018-07-02 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
1,401 -100.0%
38.78
US$54,330 		1,401 -100.0% 38.78 US$54,330
2018-07-05 2018-07-02 PlS Planned sale Patterson Matthew R

Chief Executive Officer

Executive Director
19,599 -100.0%
38.33
US$751,194 		19,599 -100.0% 38.33 US$751,194
2018-06-27 2018-06-25 PlS Planned sale NEWMAN MARY

SVP, Regulatory Affairs

Officer
300 -100.0%
41.37
US$12,412 		300 -100.0% 41.37 US$12,412
2018-06-27 2018-06-25 PlS Planned sale NEWMAN MARY

SVP, Regulatory Affairs

Officer
8,245 -100.0%
40.77
US$336,169 		8,245 -100.0% 40.77 US$336,169
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
210 -0.4%
41.27
US$8,667 		210 -0.4% 41.27 US$8,667
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
9,790 -15.7%
40.86
US$400,037 		9,790 -15.7% 40.86 US$400,037
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
100 -3.8%
41.47
US$4,147 		100 -3.8% 41.47 US$4,147
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
900 -25.3%
40.74
US$36,662 		900 -25.3% 40.74 US$36,662
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
100 -0.5%
41.46
US$4,146 		100 -0.5% 41.46 US$4,146
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
900 -4.4%
40.79
US$36,712 		900 -4.4% 40.79 US$36,712
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
1,000 -10.5%
40.78
US$40,783 		1,000 -10.5% 40.78 US$40,783
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
1,140 -0.3%
41.31
US$47,088 		1,140 -0.3% 41.31 US$47,088
2018-06-27 2018-06-25 PlS Planned sale LANGE LOUIS G
18,860 -4.6%
40.36
US$761,256 		18,860 -4.6% 40.36 US$761,256
2018-06-22 2018-06-20 PlS Planned sale Nagler David

SVP, HR & Corp. Affairs

Officer
300 -100.0%
46.02
US$13,806 		300 -100.0% 46.02 US$13,806
2018-06-22 2018-06-20 PlS Planned sale Nagler David

SVP, HR & Corp. Affairs

Officer
4,700 -100.0%
45.25
US$212,655 		4,700 -100.0% 45.25 US$212,655
2018-05-23 2018-05-21 PlS Planned sale Patterson Matthew R

President & CEO

Executive Director
6,700 -100.0%
38.30
US$256,610 		6,700 -100.0% 38.30 US$256,610
2018-05-23 2018-05-21 PlS Planned sale Patterson Matthew R

President & CEO

Executive Director
13,600 -100.0%
38.08
US$517,888 		13,600 -100.0% 38.08 US$517,888
2018-04-04 2018-04-02 PlS Planned sale Patterson Matthew R

President & CEO

Executive Director
700 -100.0%
30.01
US$21,009 		700 -100.0% 30.01 US$21,009
2018-03-28 2018-03-26 S Sale LANGE LOUIS G
6,600 -9.6%
29.27
US$193,152 		6,600 -9.6% 29.27 US$193,152
2018-03-28 2018-03-26 S Sale LANGE LOUIS G
18,400 -21.1%
28.35
US$521,666 		18,400 -21.1% 28.35 US$521,666
2018-03-28 2018-03-26 PlS Planned sale LANGE LOUIS G
483 -12.0%
29.57
US$14,282 		483 -12.0% 29.57 US$14,282
2018-03-28 2018-03-26 PlS Planned sale LANGE LOUIS G
517 -11.3%
28.32
US$14,642 		517 -11.3% 28.32 US$14,642
2018-03-28 2018-03-26 PlS Planned sale LANGE LOUIS G
400 -1.9%
29.57
US$11,829 		400 -1.9% 29.57 US$11,829
2018-03-28 2018-03-26 PlS Planned sale LANGE LOUIS G
600 -2.8%
28.38
US$17,028 		600 -2.8% 28.38 US$17,028
2018-03-28 2018-03-26 PlS Planned sale LANGE LOUIS G
500 -5.0%
29.46
US$14,732 		500 -5.0% 29.46 US$14,732
2018-03-28 2018-03-26 PlS Planned sale LANGE LOUIS G
500 -4.7%
28.28
US$14,142 		500 -4.7% 28.28 US$14,142
Explore more

More insider trading research around Audentes Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America